Zydus Lifesciences advances acquisition of Amplitude Surgical SA

Zydus Lifesciences has announced significant progress in its strategic initiatives, notably the advancement of its tender offer for Amplitude Surgical SA shares and a global licensing pact with Braile Biomedica of Brazil. Zydus has secured undertakings from seven shareholders to tender 2,236,911 Amplitude Surgical shares, representing 4.7% of the company's capital and voting rights. Combined with the 85.6% stake to be acquired from PAI Partners, the management of Amplitude Surgical, and two minority shareholders, this secures Zydus Lifesciences a position to acquire over 90% of the company. This acquisition is expected to close by June 2025, after which Zydus will file a draft tender offer with French regulatory authorities.